Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly

Clinical trial NCT00347555 · COMPLETED

Trial details

NCT number: NCT00347555
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Plasmodium Falciparum Malaria

Start date: 2006-05-01
Primary completion: 2008-04-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.